Hang B, Rothwell D G, Sagi J, Hickson I D, Singer B
Donner Laboratory, Lawrence Berkeley National Laboratory, University of California, Berkeley, California 94720, USA.
Biochemistry. 1997 Dec 9;36(49):15411-8. doi: 10.1021/bi971367s.
We have previously reported that the 3,N4-benzetheno-dC (p-BQ-dC) endonuclease activity found in HeLa cells is a novel function of the major human AP endonuclease (HAP1) [Hang et al. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 13737-13741]. In this study, we compare the enzymatic and biochemical properties of the enzyme toward p-BQ-dC and an AP site in a defined oligonucleotide. A comparative analysis of the specificity constants (Kcat./Km) for p-BQ-dC and an AP site indicates that the AP site is the preferred substrate. The enzyme does not cleave other structurally related exocyclic adducts and modified nucleosides such as 1,N6-etheno-dA, 3,N4-etheno-dC, 1, N2-etheno-dG, 1,N2-propano-dG, 8-oxo-dG, and thymine glycol. The p-BQ-dC activity requires a double-stranded DNA substrate and is affected by the base in the opposite strand, with maximal activity for a p-BQ-dC.G pair and minimal activity for a p-BQ-dC.C pair. The p-BQ-dC activity also requires Mg2+, Mn2+, or Zn2+ with optimal concentration spectra similar to those for the AP function. The optimal pH ranges for these two functions are also similar to each other (5.5-6.5). Six mutant HAP1 proteins containing single amino acid substitutions were assayed in parallel for comparison of their activities toward p-BQ-dC and the AP site. These mutants either concomitantly lost (N212A, D210N) or had reduced (D219A, E96A, and N212Q) or unchanged (H116N) p-BQ-dC and AP activities. This parallelism strongly supports the hypothesis that cleavage of p-BQ-dC requires the same catalytic active site as that proposed for the AP function. This dual activity toward two structurally unrelated substrates, an AP site and a bulky exocyclic adduct, has implications for substrate recognition. The AP site and p-BQ-dC cause different changes in the local conformation around the lesion as it is visualized by molecular modeling.
我们之前报道过,在HeLa细胞中发现的3,N4-苯并环丁烯基-dC(p-BQ-dC)内切核酸酶活性是主要人类脱嘌呤嘧啶内切核酸酶(HAP1)的一种新功能[Hang等人(1996年),《美国国家科学院院刊》93卷,13737 - 13741页]。在本研究中,我们比较了该酶对p-BQ-dC和特定寡核苷酸中一个脱嘌呤嘧啶位点的酶促及生化特性。对p-BQ-dC和脱嘌呤嘧啶位点的特异性常数(Kcat./Km)的比较分析表明,脱嘌呤嘧啶位点是更优底物。该酶不会切割其他结构相关的环外加合物和修饰核苷,如1,N6-苯并环丁烯基-dA、3,N4-苯并环丁烯基-dC、1,N2-苯并环丁烯基-dG、1,N2-丙炔基-dG、8-氧代-dG和胸腺嘧啶乙二醇。p-BQ-dC活性需要双链DNA底物,并且会受到互补链中碱基的影响,对于p-BQ-dC.G碱基对活性最高,对于p-BQ-dC.C碱基对活性最低。p-BQ-dC活性还需要Mg2+、Mn2+或Zn2+,其最佳浓度范围与脱嘌呤嘧啶功能的相似。这两种功能的最佳pH范围也彼此相似(5.5 - 6.5)。同时对六个含有单氨基酸取代的HAP1突变蛋白进行了检测,以比较它们对p-BQ-dC和脱嘌呤嘧啶位点的活性。这些突变体要么同时丧失(N212A、D210N),要么降低(D219A、E96A和N212Q),要么保持不变(H116N)p-BQ-dC和脱嘌呤嘧啶活性。这种平行关系有力地支持了这样一种假说,即p-BQ-dC的切割需要与脱嘌呤嘧啶功能所提出的相同催化活性位点。对两种结构不相关底物,即脱嘌呤嘧啶位点和一个大的环外加合物的这种双重活性,对底物识别具有重要意义。通过分子建模可以看出,脱嘌呤嘧啶位点和p-BQ-dC在损伤周围的局部构象中会引起不同的变化。